The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
First-Trimester Use of Selective Serotonin-Reuptake Inhibitors and the Risk of Birth Defects
Open accessAbstract
BACKGROUND: The risk of birth defects after antenatal exposure to selective serotonin-reuptake inhibitors (SSRIs) remains controversial. METHODS: We assessed associations between first-trimester maternal use of SSRIs and the risk of birth defects among 9849 infants with and 5860 infants without birth defects participating in the Slone Epidemiology Center Birth Defects Study. RESULTS: In analyses of defects previously associated with SSRI use (involving 42 comparisons), overall use of SSRIs was not associated with significantly increased risks of craniosynostosis (115 subjects, 2 exposed to SSRIs; odds ratio, 0.8; 95% confidence interval [CI], 0.2 to 3.5), omphalocele (127 subjects, 3 exposed; odds ratio, 1.4; 95% CI, 0.4 to 4.5), or heart defects overall (3724 subjects, 100 exposed; odds ratio, 1.2; 95% CI, 0.9 to 1.6). Analyses of the associations between individual SSRIs and specific defects showed significant associations between the use of sertraline and omphalocele (odds ratio, 5.7; 95% CI, 1.6 to 20.7; 3 exposed subjects) and septal defects (odds ratio, 2.0; 95% CI, 1.2 to 4.0; 13 exposed subjects) and between the use of paroxetine and right ventricular outflow tract obstruction defects (odds ratio, 3.3; 95% CI, 1.3 to 8.8; 6 exposed subjects). The risks were not appreciably or significantly increased for other defects or other SSRIs or non-SSRI antidepressants. Exploratory analyses involving 66 comparisons showed possible associations of paroxetine and sertraline with other specific defects. CONCLUSIONS: Our findings do not show that there are significantly increased risks of craniosynostosis, omphalocele, or heart defects associated with SSRI use overall. They suggest that individual SSRIs may confer increased risks for some specific defects, but it should be recognized that the specific defects implicated are rare and the absolute risks are small.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kessler, R. (1993) · Journal of Affective Disorders · doi:10.1016/0165-0327(93)90026-g · Cited by 2,207
Prevalence of Depression During Pregnancy: Systematic Review
Bennett, H. A., Einarson, A., Taddio, A., Koren, G., & Einarson, T. R. (2004) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000116689.75396.5f · Cited by 1,725
Birth defects and drugs in pregnancy
Heinonen, O. P., Slone, D., & Shapiro, S. (1977) · Medical Entomology and Zoology · Cited by 801
Birth Outcomes in Pregnant Women Taking Fluoxetine
Chambers, C. D., Johnson, K. A., Dick, L. M., Felix, R. J., & Jones, K. L. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610033351402 · Cited by 735
Maternal Obesity and Risk for Birth Defects
Watkins, M. L., Rasmussen, S. A., Honein, M. A., Botto, L. D., & Moore, C. A. (2003) · Pediatrics · doi:10.1542/peds.111.s1.1152 · Cited by 639
Neurodevelopment of Children Exposed in Utero to Antidepressant Drugs
Nulman, I., Rovet, J., Stewart, D. E., Wolpin, J., Gardner, H. A., Theis, J. G. W., Kulin, N., & Koren, G. (1997) · New England Journal of Medicine · doi:10.1056/nejm199701233360404 · Cited by 573
Use of Selective Serotonin-Reuptake Inhibitors in Pregnancy and the Risk of Birth Defects
Alwan, S., Reefhuis, J., Rasmussen, S. A., Olney, R. S., & Friedman, J. M. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066584 · Cited by 495
Newer antidepressants and the cytochrome P450 system
(1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.3.311 · Cited by 482
Kulin, N. A., Pastuszak, A., Sage, S. R., Schick-Boschetto, B., Spivey, G., Feldkamp, M., Ormond, K., Matsui, D., Stein-Schechman, A. K., Cook, L., et al. (1998) · JAMA · doi:10.1001/jama.279.8.609 · Cited by 424
Outcomes of Prenatal Antidepressant Exposure
Simon, G. E., Cunningham, M. L., & Davis, R. L. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.12.2055 · Cited by 386
Sanz, E. J., De-las-Cuevas, C., Kiuru, A., Bate, A., & Edwards, R. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17865-9 · Cited by 382
Preskorn, S. H. (1997) · Clinical Pharmacokinetics · doi:10.2165/00003088-199700321-00003 · Cited by 370
Hemeryck, A., & Belpaire, F. (2002) · Current Drug Metabolism · doi:10.2174/1389200023338017 · Cited by 368
Pregnancy Outcome Following First-Trimester Exposure to Fluoxetine (Prozac)
Pastuszak, A. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03500170076037 · Cited by 368
Levinson-Castiel, R., Merlob, P., Linder, N., Sirota, L., & Klinger, G. (2006) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.160.2.173 · Cited by 329
Delivery outcome after the use of antidepressants in early pregnancy
Ericson, A., Källén, B., & Wiholm, B.-E. (1999) · European Journal of Clinical Pharmacology · doi:10.1007/s002280050664 · Cited by 284
Multivitamin Supplementation and Risk of Brith Defects
Werler, M. M., Hayes, C., Louik, C., Shapiro, S., & Mitchell, A. A. (1999) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a010070 · Cited by 257
Self-citationMaternal Obesity, Gestational Diabetes, and Central Nervous System Birth Defects
Anderson, J. L., Waller, D. K., Canfield, M. A., Shaw, G. M., Watkins, M. L., & Werler, M. M. (2005) · Epidemiology · doi:10.1097/01.ede.0000147122.97061.bb · Cited by 238
Self-citationImpaired Neuropsychological Performance in Euthymic Patients With Recurring Mood Disorders
Tham, A., Engelbrektson, K., Mathe, A. A., Johnson, L., Olsson, E., & Aberg-Wistedt, A. (1997) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v58n0105 · Cited by 229
Depression during pregnancy and the puerperium.
Llewellyn, A., Stowe, Z. N., & Nemeroff, C. B. (1997) · PubMed · Cited by 226
Risks Associated With Selective Serotonin Reuptake Inhibitors in Pregnancy
Malm, H., Klaukka, T., & Neuvonen, P. J. (2005) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000187302.61812.53 · Cited by 211
Moore, L. L., Singer, M. R., Bradlee, M. L., Rothman, K. J., & Milunsky, A. (2000) · Epidemiology · doi:10.1097/00001648-200011000-00013 · Cited by 206
EFFECT OF QUESTIONNAIRE DESIGN ON RECALL OF DRUG EXPOSURE IN PREGNANCY
MITCHELL, A. A., COTTLER, L. B., & SHAPIRO, S. (1986) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a114286 · Cited by 193
Self-citationMaternal Use of Selective Serotonin Reuptake Inhibitors and Risk of Congenital Malformations
Wogelius, P., Nørgaard, M., Gislum, M., Pedersen, L., Munk, E., Mortensen, P. B., Lipworth, L., & Sørensen, H. T. (2006) · Epidemiology · doi:10.1097/01.ede.0000239581.76793.ae · Cited by 185
Antidepressant drugs during pregnancy and infant congenital heart defect
Källén, B. A. J., & Olausson, P. O. (2006) · Reproductive Toxicology · doi:10.1016/j.reprotox.2005.11.006 · Cited by 149
Systematic Identification of Drugs That Cause Birth Defects — A New Opportunity
Mitchell, A. A. (2003) · New England Journal of Medicine · doi:10.1056/nejmsb031395 · Cited by 141
Self-citationUse of Psychoactive Medication During Pregnancy and Possible Effects on the Fetus and Newborn
(2000) · PEDIATRICS · doi:10.1542/peds.105.4.880 · Cited by 140
Birth outcomes following prenatal exposure to fluoxetine
Cohen, L. S., Heller, V. L., Bailey, J. W., Grush, L. R., Ablon, J. S., & Bouffard, S. M. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00877-5 · Cited by 137
Citalopram use in pregnancy: Prospective comparative evaluation of pregnancy and fetal outcome
Sivojelezova, A., Shuhaiber, S., Sarkissian, L., Einarson, A., & Koren, G. (2005) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2005.05.012 · Cited by 128
Birth Defects Related to Bendectin Use in Pregnancy: I. Oral Clefts and Cardiac Defects
Mitchell, A. A. (1981) · JAMA · doi:10.1001/jama.1981.03310470025020 · Cited by 125
Self-citationDr. Nemeroff and Colleagues Reply
Nemeroff, C. B., DEVANE, C. L., & Pollock, B. G. (1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.12.1656 · Cited by 124
Association between maternal obesity and fetal cardiac malformations in African Americans.
Mikhail, L., Walker, C. K., & Mittendorf, R. L. (2002) · PubMed · Cited by 60
Birth defects in relation to Bendectin use in pregnancy
Mitchell, A. A., Schwingl, P. J., Rosenberg, L. A., Louik, C., & Shapiro, S. (1983) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(83)90028-5 · Cited by 45
Self-citationStudies of Drug‐Induced Birth Defects
Mitchell, A. A. (2006) · Pharmacoepidemiology · doi:10.1002/9780470059876.ch32 · Cited by 35
Self-citationAbdulla, R. (1998) · Pediatric Cardiology · doi:10.1007/s002469900346 · Cited by 12
Cited by
Donofrio, M. T., Moon-Grady, A. J., Hornberger, L. K., Copel, J. A., Sklansky, M. S., Abuhamad, A., Cuneo, B. F., Huhta, J. C., Jonas, R. A., Krishnan, A., et al. (2014) · Circulation · doi:10.1161/01.cir.0000437597.44550.5d · Cited by 1,275
Anderson, I., Ferrier, I., Baldwin, R., Cowen, P., Howard, L., Lewis, G., Matthews, K., McAllister-Williams, R., Peveler, R., Scott, J., et al. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881107088441 · Cited by 908
Fawcett, E. J., Fairbrother, N., Cox, M. L., White, I. R., & Fawcett, J. M. (2019) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.18r12527 · Cited by 609
Yatham, L. N., Kennedy, S. H., Schaffer, A., Parikh, S. V., Beaulieu, S., O'Donovan, C., MacQueen, G., McIntyre, R. S., Sharma, V., Ravindran, A., et al. (2009) · Bipolar Disorders · doi:10.1111/j.1399-5618.2009.00672.x · Cited by 570
Use of Selective Serotonin-Reuptake Inhibitors in Pregnancy and the Risk of Birth Defects
Alwan, S., Reefhuis, J., Rasmussen, S. A., Olney, R. S., & Friedman, J. M. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066584 · Cited by 495
Metadata
- Authors
- Louik, C., Lin, A. E., Werler, M. M., Hernández-Díaz, S., & Mitchell, A. A.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2007-06-28
- Volume
- 356
- Issue
- 26
- Pages
- 2675-2683
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2062240933
- Cited by
- 500
- References
- 35
- FWCI
- 53.14
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.